21+ only. Kratom is not FDA-approved and is not intended to diagnose, treat, cure, or prevent any disease. Kratom is not legal in all U.S. jurisdictions — full bans are in effect in Alabama, Arkansas, Connecticut, Indiana, Kansas, Louisiana, Tennessee, Vermont, Wisconsin, and Washington, D.C. Verify your local laws before ordering. This article is informational only and is not legal or medical advice.

The 2026 Kratom Regulation Landscape: New Bans, KCPAs & Federal Action

Leaf Notes · Published July 9, 2026 · 10 min read

More kratom law changed in the twelve months ending July 2026 than in the entire preceding decade. Three states enacted full bans that took effect this year. One state — for the first time in U.S. history — reversed a ban. California built a de facto commercial prohibition without passing a single statute. And on July 1, the DEA moved against concentrated 7-OH at the federal level. Here is the complete picture, verified against primary sources, as of mid-July 2026.

This is the news-and-changes companion to our evergreen state-by-state legality hub. For the baseline rules in every state, start there; this guide covers what changed, why, and what is still in motion. Laws move fast — always verify current status with official sources before acting on anything here.

The Full-Ban States: Now Nine, Plus D.C.

As of July 2026, nine states fully prohibit kratom: Alabama, Arkansas, Connecticut, Indiana, Kansas, Louisiana, Tennessee, Vermont, and Wisconsin. Washington, D.C. also treats 7-OH as Schedule I. Three of the nine are new within the past year:

Tennessee — effective July 1, 2026

House Bill 1649 and companion SB 1656 — "Matthew Davenport's Law," named for a 27-year-old Chattanooga man who died in 2024 following a lethal interaction between kratom and prescribed medications — passed both chambers on April 16, 2026 (House 78–9, Senate 23–3), was signed by Governor Bill Lee as Public Chapter 950, and took effect July 1, 2026. Knowing possession is a Class A misdemeanor; manufacture, delivery, or sale is a Class C felony; sale to a minor by an adult at least two years older is a Class B felony. The law also requires medical examiners to test for kratom in suspected overdose autopsies. Full breakdown: Tennessee's kratom ban explained.

Kansas — effective July 1, 2026

Governor Laura Kelly signed House Bill 2365 on April 10, 2026, adding 7-OH and kratom-related substances to Schedule I of the Kansas Uniform Controlled Substances Act (K.S.A. 65-4105), with companion Senate action adding mitragynine. Both took effect July 1, 2026. Because the scheduling covers the plant's core alkaloids without a natural-leaf carve-out, the practical effect is a complete ban on kratom products statewide. Details: what changed in Kansas on July 1.

Connecticut — effective spring 2026

Connecticut's path ran through Public Act 25-101, signed in June 2025, which directed the Department of Consumer Protection to schedule seven substances including kratom, 7-OH, tianeptine, and phenibut. The Legislative Regulation Review Committee unanimously approved the Schedule I regulations on February 24, 2026; the DCP directed retailers to remove or return products by March 25, 2026; and the regulations received final approval on April 2, 2026 and are now in effect. Connecticut described itself as the seventh state to schedule kratom and its derivatives. Details: Connecticut's scheduling explained.

The legacy bans, and Louisiana's 2025 addition

The other six full-ban jurisdictions predate this year's wave. Indiana and Wisconsin classified kratom's alkaloids as synthetic drugs back in 2014; Alabama, Arkansas, and Vermont scheduled them in 2016. Louisiana is the most recent of the pre-2026 group — its ban took effect August 1, 2025, placing kratom in Schedule I with penalties reaching up to five years and $50,000 for distribution offenses. Washington, D.C. presents a narrower case: its regulations list 7-hydroxymitragynine as Schedule I, while the status of natural leaf and mitragynine is less clearly addressed — one more reason careful vendors simply refuse D.C. shipments rather than litigate the ambiguity.

It is worth pausing on how differently these nine laws are built. Indiana and Wisconsin reached kratom through synthetic-drug statutes; Alabama and Arkansas through direct alkaloid scheduling; Tennessee through a purpose-built criminal statute with autopsy-testing mandates; Kansas through an omnibus controlled-substances update that also touched fentanyl analogs and hexahydrocannabinol. The destination is the same — no legal kratom — but the statutory vehicles vary enormously, which is why penalty structures range from Tennessee's Class A misdemeanor for possession to Kansas's drug severity level 5 felony for a first possession offense. If you live in or travel through any of these states, the safe assumption is total prohibition of every kratom product in every format.

The Historic First: Rhode Island Reversed Its Ban

Against the prohibition wave, Rhode Island did something no U.S. state had ever done: it moved kratom from banned back to regulated-legal. The state had prohibited mitragynine and 7-OH since 2017 via Department of Health action. The Rhode Island Kratom Act (R.I. Gen. Laws Ch. 21-28.12) took effect April 1, 2026, replacing prohibition with a Kratom Consumer Protection Act framework: legal for adults 21 and older, with mandatory labeling, third-party laboratory testing, limits on 7-OH concentration, and a prohibition on synthetic alkaloid additives.

Advocates' core argument — that the ban pushed Rhode Islanders toward unregulated out-of-state and online products rather than reducing use — carried the legislature. Whether the reversal becomes a template or an outlier is one of the biggest open questions in kratom policy. Our full analysis: why Rhode Island's reversal matters.

California: Prohibition Without a Statute

California never scheduled kratom. Instead, on October 24, 2025, the California Department of Public Health declared that foods, supplements, and drugs containing kratom or 7-OH are adulterated under the Sherman Food, Drug, and Cosmetic Act — and therefore illegal to manufacture or sell for consumption at any age. Enforcement escalated through early 2026: Alcoholic Beverage Control agents began retailer education visits January 19, full enforcement started February 9, and by March 3 Governor Newsom announced 95 percent retailer compliance, with more than 3,300 products pulled and over $5 million in product seized. In May, CDPH sued a Santee manufacturer for continuing production.

Two nuances matter. First, personal possession is not criminalized at the state level — the action targets commercial sale and manufacture. Second, a regulatory alternative is alive: AB 1088, which would create age limits, testing requirements, and 7-OH restrictions rather than prohibition, passed the Assembly and sits in the Senate Health Committee. Full picture: California's CDPH enforcement explained.

The KCPA Majority

Prohibition headlines obscure the larger trend: more than thirty states now regulate kratom under Kratom Consumer Protection Act frameworks — age minimums (typically 21+), labeling and alkaloid-disclosure requirements, mandatory testing, and bans on synthetic or adulterated products. Utah enacted the first KCPA in 2019; the model has since spread across the country, and Rhode Island's 2026 reversal used it as the landing zone. New York and Mississippi both raised their minimum purchase age to 21 in July 2025, aligning with the framework even without full adoption, and a 2026 Public Health Reports commentary flagged the next frontier: ready-to-drink kratom beverages that postdate most KCPA drafting and slip through older statutes without alkaloid disclosure or age checks. For buyers, KCPA states are where the market works as intended: tested, labeled, age-gated natural leaf from accountable vendors.

Why Some States Ban and Others Regulate

The 2026 split between ban states and KCPA states is not random — it tracks three recurring fault lines in the legislative record.

First, the triggering event. Tennessee's law is named for a specific constituent death; the bill's sponsors called kratom "gas station heroin" on the floor, and the personal story carried a 78–9 House vote. Kansas legislators pointed to Johnson County's elevated rate of kratom-related EMS encounters. Where a state's debate is anchored to a tragedy or a local health statistic, prohibition tends to win. Where the debate is anchored to product-quality scandals — mislabeled potency, contaminated imports — regulation tends to win, because testing and labeling directly answer the problem.

Second, the 7-OH conflation. Several 2026 ban debates treated concentrated 7-OH products and natural leaf as a single category, and the retail reality — both sold side by side in the same gas-station coolers — made the conflation easy. States that separated the two analytically (Ohio, Florida, Mississippi, Colorado) restricted the concentrates and left leaf alone or regulated it. States that did not separate them (Tennessee, Kansas, Connecticut) banned everything. The DEA's threshold-based federal approach may push future state debates toward the distinction, which would favor the regulate-don't-ban outcome.

Third, the enforcement question. Rhode Island's reversal was argued almost entirely on enforcement economics: a decade of prohibition had not reduced use, had zero effect on out-of-state online supply, and left residents buying untested product. Legislators who found that argument persuasive concluded that a tested, age-gated, 7-OH-capped legal market protects residents better than a ban that only controls what sits on in-state shelves. Every future reversal campaign will run on the same logic — and every ban state generates the same data for it.

The Federal Layer: 7-OH Scheduling

On July 1, 2026, the DEA filed two Notices of Intent to temporarily place concentrated 7-OH (above a 0.050 percent dry-weight threshold for botanical material) and three synthetic related substances — mitragynine pseudoindoxyl, MGM-15, and MGM-16 — into Schedule I. HHS confirmed the statutory findings and opened a public comment docket (HHS-OASH-2026-0232) that closes July 31, 2026. The notices were published in the Federal Register July 6, with temporary orders expected roughly 30 days later. Natural leaf below the threshold remains federally unscheduled.

Separately, a group of senators led by Pete Ricketts urged the FDA in March 2026 to pursue federal scheduling of kratom itself — the most significant federal-ban pressure since the DEA's withdrawn 2016 attempt. Nothing has come of it yet, but it marks where one flank of the debate wants to go. The full mechanics of the DEA action are in our 7-OH vs natural leaf pillar and DEA scheduling explainer.

Twelve Months That Rewrote the Map

Laid end to end, the pace of change is easier to see:

DateEvent
Aug 1, 2025Louisiana's Schedule I kratom ban takes effect
Oct 24, 2025California CDPH declares kratom and 7-OH products adulterated and illegal to sell or manufacture
Dec 12, 2025Ohio Board of Pharmacy issues emergency rule against synthetic kratom compounds (natural leaf excluded Dec 16)
Feb 9, 2026California moves from retailer education to full enforcement
Feb 24, 2026Connecticut's Regulation Review Committee approves Schedule I designation for kratom and 7-OH
Mar 3, 2026Governor Newsom announces 95% California retailer compliance; $5M+ in products seized
Mar 18, 2026Michigan House passes a kratom ban; Senate consideration pending
Apr 1, 2026Rhode Island Kratom Act takes effect — first ban reversal in U.S. history
Apr 10, 2026Kansas Governor Kelly signs HB 2365
Apr 16, 2026Tennessee's Matthew Davenport's Law passes both chambers; signed as Public Chapter 950
Mid-May 2026Ohio's permanent Schedule I rule for synthetic mitragynine-related compounds takes effect
Jul 1, 2026Tennessee and Kansas bans take effect; DEA files notices of intent on concentrated 7-OH
Jul 6, 2026DEA notices published in the Federal Register; HHS comment docket opens
Jul 31, 2026HHS RFI comment window closes (docket HHS-OASH-2026-0232)

Three ban effective dates, one reversal, a statewide administrative crackdown, and the first federal scheduling action against a kratom-derived compound — all inside a single year. No other botanical category in the U.S. moved this fast in 2026.

Still in Motion: What to Watch Through Late 2026

JurisdictionWhat's pendingWhy it matters
Federal (DEA/HHS)Temporary 7-OH scheduling orders expected ~early August; RFI comments close July 31First federal scheduling of any kratom-derived substance
MichiganHouse passed a ban March 18, 2026; Senate consideration pendingWould become the tenth full-ban state
OhioNatural-leaf Schedule I rule under Common Sense Initiative review; SB 299/HB 587 regulation bills pendingOhio could land on either side — ban or regulate
CaliforniaAB 1088 (regulate, don't ban) in Senate Health CommitteeWould replace the CDPH enforcement regime with a KCPA-style framework
Georgia, South Carolina, WashingtonBills to repeal KCPAs and ban (GA HB968, SC H.4636/4641/4648) or tax heavily (WA SB 6196's proposed 95% excise)Tests whether KCPA states hold the line

Ban bills were also introduced in 2026 sessions in Illinois, West Virginia, Wyoming, and Maryland; introduction alone predicts little, but the volume shows which way legislative energy is flowing.

What This Means for Buyers and for This Site

A note on travel, since it is the most common practical question the new map raises. Kratom that is perfectly legal at home becomes contraband the moment you cross into a ban state — and in Tennessee or Kansas that now means misdemeanor or felony exposure, not a citation. Driving through a ban state with kratom in the vehicle, flying with it through a connecting airport in one, or having a package forwarded across state lines into one all create real legal risk. The conservative rule is simple: do not carry kratom into any of the nine ban states or D.C. for any reason, and if your travel routes through them regularly, buy at your destination in a legal state instead of transporting.

Just Kratom

Shop Just Kratom →

Just Kratom's lab-tested powders, capsules, and gummies ship only to jurisdictions where kratom remains legal.

Not available for shipment to jurisdictions where kratom is prohibited. 21+ only.

The 2026 landscape rewards exactly one kind of participant: tested, transparent, age-gated natural leaf, sold only where the law allows. That has been this site's screen from day one, and every vendor we feature is held to it.

Frequently Asked Questions

How many states ban kratom in 2026?

Nine states fully ban kratom as of July 2026: Alabama, Arkansas, Connecticut, Indiana, Kansas, Louisiana, Tennessee, Vermont, and Wisconsin. Washington, D.C. schedules 7-OH. California separately blocks commercial sale through CDPH administrative enforcement without scheduling kratom.

Which kratom bans are new in 2026?

Three: Connecticut (Schedule I regulations approved February 24, 2026, final approval April 2), Kansas (HB 2365, effective July 1, 2026), and Tennessee (HB 1649, Matthew Davenport's Law, effective July 1, 2026).

Has any state ever un-banned kratom?

Yes — Rhode Island, effective April 1, 2026. The Rhode Island Kratom Act replaced the state's 2017 prohibition with a regulated framework: 21+, mandatory testing and labeling, 7-OH limits, and a ban on synthetic alkaloids. It is the first reversal of a kratom ban in U.S. history.

Is kratom federally legal in 2026?

Natural kratom leaf remains federally unscheduled. On July 1, 2026, the DEA filed notices of intent to temporarily schedule concentrated 7-OH above a 0.050 percent dry-weight threshold and three synthetic related compounds; temporary orders are expected in early August 2026.

What is a Kratom Consumer Protection Act?

Model state legislation that regulates rather than bans kratom: minimum purchase age (typically 21), mandatory third-party lab testing, labeling with alkaloid content, and prohibitions on synthetic or adulterated products. More than thirty states have adopted KCPA frameworks as of 2026.